<div dir="ltr">Dear All,<div><br></div><div>My apologies as the slides are not quite ready.</div><div>That was a typo. But I will send them once they are ready.</div><div><br></div><div>Our discussion will be focusing on the pros and cons of Closed Generics and possible harm.</div><div><br></div><div>Kind regards,</div><div><br></div><div>Michael Flemming</div><div class="gmail_extra"><br>
<br><div class="gmail_quote">On Mon, Mar 27, 2017 at 9:34 PM, Michael Flemming <span dir="ltr"><<a href="mailto:flemming@brightsconsulting.com" target="_blank">flemming@brightsconsulting.com</a>></span> wrote:<br><blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex"><div dir="ltr"><span style="font-size:12.8px">Dear All,</span><div style="font-size:12.8px"><br></div><div style="font-size:12.8px">This week on 30 March 2017 at 21 UTC we will be continuing our discussion on Closed Generics. Below is the agenda.</div><div style="font-size:12.8px"><br></div><div style="font-size:12.8px"><ol><li style="margin-left:15px"><i>Welcome<br><br></i></li><li style="margin-left:15px"><i>SOI<br><br></i></li><li style="margin-left:15px"><i>Closed Generics</i><br><br></li><li style="margin-left:15px"><i>AOB</i></li></ol><div><br></div><div>Also, I send to everyone the slides that I plan to use for the meeting.</div><div><br></div><div>I look forward to speaking with everyone and having an exciting conversation!</div><div><br></div><div>Kind regards,</div><div><br></div><div>Michael Flemming</div></div>
</div>
</blockquote></div><br></div></div>